Bengaluru: Aster DM Healthcare Limited today announced that it has received an overwhelming 96.68% voting approval from shareholders along with a significant majority of minority shareholders and creditors voting in favour of the proposed Scheme of Amalgamation with Quality Care India Limited (QCIL). The approval follows support from the Company’s shareholders, in favour of the share swap preceding the merger, reflecting broad-based investor support for the overall transaction. The merger is expected to be completed in the next quarter, post receipt of remaining regulatory and statutory NCLT approvals.
Commenting the strong positive voting, Dr. Azad Moopen, Founder Chairman, Aster DM Healthcare said, “The strong support from our shareholders reflects their confidence in the strategic rationale of this merger and the long-term value it will deliver. By bringing together Aster DM Healthcare and Quality Care India, we are building a scaled, future-ready healthcare platform with the clinical depth, operational strength and governance framework required to serve millions of patients across the country. This partnership combines Aster’s legacy of patient-centric care and physician leadership with the institutional strength and growth expertise of Blackstone. Together, we are well positioned to expand access to high-quality healthcare, invest in clinical excellence and innovation, and create one of India’s leading integrated healthcare networks.”
Upon completion, the combined entity is expected to emerge as one of the top three hospital chains in India, with a diversified presence across 9 states and 28 cities. The merged platform will operate 39 hospitals with 10,625+ beds, supported by over 36,307+ employees and clinicians, serving millions of patients annually across hospitals, clinics, laboratories and allied healthcare services.
India continues to be Aster’s largest growth market. Looking ahead, the merged entity aims to increase total bed capacity to around 14,710+ beds over the coming years. Of the planned 4,080+ bed additions by the combined platform, approximately 2,368 beds will be added by Aster, while the remaining capacity expansion will be driven by QCIL. Aster’s expansion will be supported by a capital outlay of approximately ₹2,300 crore, of which ₹350 crore has already been invested in critical projects as of September 2025.
The company plans to add ~2,368 beds across the country through a mix of greenfield projects and selective acquisitions, strengthening its presence in key states such as Kerala and Karnataka, where it already holds a strong position. Key upcoming additions include two new hospitals in Bengaluru — a 430-bed facility on Sarjapur Road and a 500-bed hospital in Yeshwanthpur. The company will also add 350 beds at Aster CMI Hospital and 159 beds at Aster Whitefield, further reinforcing Aster’s leadership position among the top three healthcare providers in the city.
In Kerala, the 263-bed Aster Kasaragod Hospital became operational in October 2025. Additionally, the 454-bed greenfield Aster Capital Hospital in Trivandrum is currently under development, while Aster Medcity, Kochi is being expanded with the addition of 100 beds. Other planned projects include a 300-bed Women & Children’s Hospital in Hyderabad and a 75-bed expansion at Aster Ramesh Hospital in Ongole.
